Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCBT with TMI Conditioning for Refractory/Relapsed Aplastic Anemia
NCT07078721Phase 2Not yet recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2028
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
umbilical cord blood
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07078721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07078721.